cosyntropin - Profile
What are the generic sources for cosyntropin and what is the scope of freedom to operate?
Cosyntropin
is the generic ingredient in two branded drugs marketed by Amphastar Pharms Inc, Pharmobedient, and Sandoz, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.Summary for cosyntropin
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 3 |
| NDAs: | 4 |
US Patents and Regulatory Information for cosyntropin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphastar Pharms Inc | CORTROSYN | cosyntropin | INJECTABLE;INJECTION | 016750-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharmobedient | COSYNTROPIN | cosyntropin | INJECTABLE;INJECTION | 090574-001 | Dec 17, 2009 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sandoz | COSYNTROPIN | cosyntropin | INJECTABLE;INJECTION | 202147-001 | Jun 29, 2012 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sandoz | COSYNTROPIN | cosyntropin | SOLUTION;INTRAVENOUS | 022028-001 | Feb 21, 2008 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
